GMED · earnings call history
Globus Medical Q2 FY26 — Strong Spine Growth and Margin Expansion Drive EPS Beat
Read the briefGlobus Medical Q1 FY26 — Strong Top-line Growth and Raised EPS Guidance
Read the briefGlobus Medical Q4 FY25 — Record Performance Driven by U.S. Spine and Enabling Technologies
Read the briefBrowse all US companies on the earnings-call register.